|
Oct 1
|
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
|
|
Sep 30
|
Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc
|
|
Sep 30
|
Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding
|
|
Sep 30
|
High Growth Tech Stocks To Watch For Future Potential
|
|
Sep 25
|
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
|
|
Sep 8
|
BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?
|
|
Sep 5
|
BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
|
|
Sep 4
|
BioMarin, having retrenched, outlines plans for growth
|
|
Sep 4
|
BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
|
|
Sep 4
|
Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?
|
|
Sep 4
|
BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time
|
|
Sep 4
|
Zacks.com featured highlights include Wolverine World Wide, BioMarin Pharmaceutical, Datadog, Progressive and Klaviyo
|
|
Aug 30
|
Exploring Three High Growth Tech Stocks In The United States
|
|
Aug 29
|
BioMarin lays off 225 employees in restructuring efforts
|
|
Aug 29
|
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock
|
|
Aug 29
|
BioMarin to lay off over 200 employees
|
|
Aug 29
|
BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
|
|
Aug 29
|
The most expensive drugs in the US
|
|
Aug 28
|
Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
|
Aug 28
|
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
|